{"id":10111,"date":"2019-11-27T00:00:00","date_gmt":"2019-11-26T23:00:00","guid":{"rendered":"https:\/\/idibell.cat\/es\/blog\/2019\/11\/27\/resolucion-de-la-convocatoria-de-expresion-de-interes-eoi-para-proyectos-de-colaboracion-en-medicina-regenerativa-2019\/"},"modified":"2020-05-19T11:19:03","modified_gmt":"2020-05-19T09:19:03","slug":"resolucion-de-la-convocatoria-de-expresion-de-interes-eoi-para-proyectos-de-colaboracion-en-medicina-regenerativa-2019","status":"publish","type":"post","link":"https:\/\/idibell.cat\/es\/2019\/11\/resolucion-de-la-convocatoria-de-expresion-de-interes-eoi-para-proyectos-de-colaboracion-en-medicina-regenerativa-2019\/","title":{"rendered":"Resoluci\u00f3n de la convocatoria de expresi\u00f3n de inter\u00e9s (EoI) para proyectos de colaboraci\u00f3n en medicina regenerativa 2019"},"content":{"rendered":"
Once the period for applications submission is finished, all the documentation provided has been reviewed and the list for funded EoI is approved.<\/p>\n
The Assessment Committee, met on October 8th, in accordance with the criteria described in the call, has evaluated the Collaborative Projects and has raised a list of proposals selected to be funded.<\/p>\n
Therefore, I resolve to,<\/p>\n
This funding will be compatible with any other one received for the same purpose, coming from any public or private, national or international funding body.<\/p>\n
Barcelona, 25th November 2019.<\/p>\n
\u00c1ngel Raya Chamorro<\/p>\n
Director of the Centre for Regenerative\u00a0Medicine of Barcelona (CMR[B])<\/p>\n
Gabriel Capell\u00e1 i Munar<\/p>\n
Director of the Bellvitge Biomedical\u00a0Research Institute (IDIBELL)<\/p>\n
PROJECTS, IPs AND BUDGETS:<\/p>\n
–New neurovascular remodelling strategies for neurorepair after stroke: from nanomedicine to neurorehabilitation therapies.<\/strong><\/p>\n Anna Rosell Novell. Vall d’Hebron Institute of Research (VHIR). 10.000 \u20ac<\/p>\n –Blood cell regeneration from pluripotent stem cells.<\/strong><\/p>\n Anna Bigas Salvans. Fundaci\u00f3 Institut Mar d’Investigacions M\u00e8diques (IMIM). 10.000 \u20ac<\/p>\n –Cardiac engineered tissues for myocardial infarction: from pre-clinical validation to clinical translation.<\/strong><\/p>\n Carolina G\u00e1lvez-Mont\u00f3n. Germans Trias i Pujol Health Science Research Institute (IGTP). 10.000 \u20ac<\/p>\n –Regenerating aged kidney function by targeting Cdc42 and senescent cells in human renal parietal epithelial cells (PECs).<\/strong><\/p>\n Anna Sola Mart\u00ednez. Bellvitge Biomedical Research Institute (IDIBELL). 10.000 \u20ac<\/p>\n –Transplantation of human iPS cells-derived RPE cell suspension for Age Related Macular Degeneration (AMD). First-in man clinical trial.<\/strong><\/p>\n Anna Veiga Lluch. Bellvitge Biomedical Research Institute (IDIBELL). 10.000 \u20ac<\/p>\n –Culture, expansion and differentiation of human pancreatic organoids in a 3D hydrogel-based platform using selfassembling peptide nanofibers functionalized with instructive peptides.<\/strong><\/p>\n Eduard Montanya Mias.\u00a0Bellvitge Biomedical Research Institute (IDIBELL).\u00a010.000 \u20ac<\/p>\n